SPP1 and Sjogren syndrome: In patients with myositis, heart manifestations, and sicca-syndrome antibody prevalence and reactivity towards AT1R, ETA1 or topo-I did not differ from that in patients without these symptoms (Figures 3F, I, K and Supplement Table S5).